U.S. Oil and Gas Stock News

Investor attention around Dave (DAVE) has picked up ahead of the upcoming August 5 earnings report, with expectations focused on higher earnings and revenues and the possibility that results could exceed current market estimates. See our latest analysis for Dave. Despite the recent pullback, with a 1 day share price return down 6.76% and a 7 day share price return down 10.54%, Dave still shows strong momentum, with a 90 day share price return of 39.34% and a 1 year total shareholder return of...

KKR stock is caught between two conflicting valuation signals right now, with the intrinsic value estimate from the Excess Returns model pointing to some upside while market based multiples suggest the shares are priced on the richer side after a mixed return profile. Over the past 3 years KKR has returned 72.1%, which shows the stock has already delivered strong gains over a medium term holding period. Recent deal activity in energy and infrastructure, such as the agreed DCC Energy takeover...

Pitney Bowes Inc. has reported past second-quarter 2026 results showing revenue of US$451.5 million versus US$461.91 million a year earlier, while net income rose to US$49.91 million from US$29.98 million, alongside reaffirmed full-year 2026 revenue guidance, continued share repurchases, and a US$0.10 quarterly dividend approval. Despite lower revenue, the company delivered higher earnings per share, completed a large portion of its buyback program, and added experienced deal-maker La Vonda...

Earlier this week, analysts highlighted that Trex Company is expected to report a year-over-year earnings decline on higher revenues for the June 2026 quarter, with consensus EPS estimates revised upward over the past month but still pointing to weaker profitability. An interesting wrinkle is that Trex currently carries a top-tier Zacks Rank alongside a negative Earnings ESP, underscoring how diverging analyst signals are sharpening attention on the upcoming results. Next, we’ll examine how...

Strategic Education (STRA) drew fresh attention on July 29, 2026, after reporting second quarter earnings and confirming a regular quarterly cash dividend of $0.60 per share for shareholders. See our latest analysis for Strategic Education. The earnings surprise appears to have shifted sentiment toward Strategic Education, with a 7.65% 1-day share price return and 16.83% 7-day share price return, while the 1-year total shareholder return of 21.76% points to momentum building rather than...

Inflation, central bank decisions and energy prices are keeping markets on edge, which makes it harder to rely on short term signals. Founder led companies offer a different anchor. These leaders often have reputations, wealth and careers tied directly to the long term outcome of their stock. The Founder-Led Companies screener focuses on this alignment. It does not track a single sector or story, which can help you stay flexible as conditions change. In this article you will see three stocks...

Omega Healthcare Investors has delivered a strong 115.8% total return over the past five years, and the latest valuation work suggests the stock may still trade below an estimate of intrinsic value based on Discounted Cash Flow, rather than looking stretched after that run. A 115.8% return over five years suggests long term holders in Omega Healthcare Investors have already been well rewarded. Any further upside case now rests on whether the current price still leaves a margin against...

Galaxy Digital Inc. recently acquired approximately 500 acres in McGregor, Texas, under a development agreement to build an AI and high-performance computing data center campus, initially targeting 74 megawatts of capacity with power expected to begin flowing in 2028. This second Texas campus signals Galaxy’s push to build a multi-campus data center platform and deepen its role in the AI infrastructure supply chain. We’ll now examine how the planned 74-megawatt McGregor AI campus could...

ArcBest (ARCB) is back in focus after its latest quarterly report, which combined higher sales with a swing to a net loss and arrived alongside fresh details on restructuring, buybacks, and dividends. See our latest analysis for ArcBest. ArcBest’s share price has pulled back recently, with a 1 day share price return of 5.35% lower and a 7 day share price return of 11.22% lower following the impairment and restructuring announcements. However, the year to date share price return of 83.35% and...

Marex Group (MRX) stock has drawn attention after recent trading performance, with the price closing at US$63.14. Investors are weighing this move against the company’s latest financial metrics and business mix. See our latest analysis for Marex Group. For context, Marex Group’s recent pullback, with a 1-day share price return of 1.59% lower and 7-day share price return of 4.12% lower, comes after strong momentum. This includes a 30-day share price return of 7.13%, a 90-day share price return...

Upstart Holdings (NasdaqGS:UPST) announced a new multi-year forward-flow loan agreement with Castlelake. The program totals up to US$4b in committed funding capacity for Upstart-powered loans. This is the largest forward-flow program between Upstart and Castlelake so far. Upstart Holdings operates an AI-driven lending platform that connects consumers, banks and credit unions. Access to committed funding is central for a company that depends on third-party capital providers to purchase and...

Agnico Eagle Mines (NYSE:AEM) just reported quarterly results that topped Wall Street earnings expectations while keeping its 2026 production outlook and dividend intact. For investors, that combination puts the latest stock move into clearer context. See our latest analysis for Agnico Eagle Mines. The latest quarterly beat and confirmation of guidance come after a share price that has fallen 23.3% over three months and 15.3% year to date, even as Agnico Eagle Mines has delivered a 3 year...

Atlassian stock has staged a sharp short term rebound but sits on a long stretch of weak returns, which contrasts with valuation checks that currently lean toward the shares looking cheap on several standard measures. Over the past 5 years, Atlassian has delivered a cumulative decline of 69.4%, which frames today’s share price near US$104 as a recovery off a much lower base rather than a long run success story. Expectations around Atlassian’s ability to convert its software revenue into...

US cybersecurity stocks sit at the crossroads of two powerful forces. On one side are rising concerns about AI being misused in hacks and cross border data theft. On the other are signs that regulators may tighten control of high risk AI tools after recent OpenAI related incidents. That mix can pressure some AI heavy giants while potentially giving select security focused players a relative edge. This article looks at 3 US cybersecurity stocks from the screener that appear closely exposed to...

In late July 2026, several law firms announced class action lawsuits against PROCEPT BioRobotics alleging that an undisclosed discount program led customers to buy handpiece units in volumes that materially exceeded procedure demand, inflating reported U.S. sales and creating more than 10,000 excess units of field inventory by the end of 2025. The complaints also claim PROCEPT’s guidance for 2025 lacked a reasonable factual basis because management allegedly knew pulled-forward sales and...

Circle Internet Group (NYSE:CRCL) has acquired nearly 1,000 blockchain patents from IBM. The deal is aimed at supporting the company’s USDC stablecoin and related financial tools. This move adds a large portfolio of crypto infrastructure intellectual property to Circle’s existing platform. Circle Internet Group is making this move at a time when the stock has come under pressure. NYSE:CRCL closed at $61.36, with the share price down 7.3% over the past week, 19.2% over the past month, and...

CG Oncology recently reported that The Lancet Oncology published pivotal Phase 3 BOND-003 Cohort C data showing cretostimogene grenadenorepvec monotherapy achieved statistically significant complete responses with durable outcomes and a favorable safety profile in high-risk, BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ. The trial results suggest cretostimogene could fit smoothly into everyday urology practice because it avoids operating room time, anesthesia...

Earlier this week, workplace furnishings maker HNI Corporation announced it would release quarterly earnings before market open on Thursday, with analysts expecting revenue to grow very sharply year on year from the same period last year. This earnings report carries extra weight because HNI has missed Wall Street revenue forecasts multiple times over the past two years, sharpening focus on whether it can now meet heightened expectations. We’ll now examine how expectations for a very large...

Oil price swings and fresh conflict headlines in the Gulf are again front and center for markets. When missiles fly and supply routes face new questions, some stocks with close ties to energy pricing and global trade can see sharp moves, both positive and negative. This article focuses on three stocks from our Oil Volatility and Geopolitical Risk Stock Opportunities screener that are directly exposed to the latest U.S. and Iran flare up. You will see how each one might react to higher oil...

Boston Scientific stock has fallen about 56.9% over the past year, yet the valuation checks still lean supportive, which raises the question of whether the share price has moved further than the fundamentals suggest. The roughly 56.9% decline over the last 12 months means existing shareholders have taken a heavy hit, while potential new buyers are looking at a much lower entry point. The global restructuring plan that targets lower ongoing costs can support valuation over time. However, the...

UiPath (PATH) continues to draw attention after recent trading left the stock at a last close of US$12.59. Investors are weighing its automation platform, international footprint and current share performance across different timeframes. See our latest analysis for UiPath. The recent 1 day share price return of 3.28% and 7 day share price return of 17.66% sit against a year to date share price decline of 20.72%, while the 1 year total shareholder return of 4.83% points to mixed but improving...

CME Group (CME) is drawing fresh attention after outlining new single stock futures, a FutureSports performance index partnership, recent Q2 earnings, and ongoing share buybacks, giving investors several developments to assess together. See our latest analysis for CME Group. The latest product launches and FutureSports partnership sit alongside a sharp 21.44% 1 month share price return and a 6.50% 7 day gain, even though the 1 year total shareholder return is slightly negative and the 3 year...

Coupang (CPNG) has just entered the 2026 Fortune Global 500 list following years of investment in AI, robotics, and logistics infrastructure. This recognition puts the company’s global scale in sharper focus for investors. See our latest analysis for Coupang. Despite Coupang’s new place on the Fortune Global 500 and its upcoming August 4 earnings report, recent trading has been weak, with the share price down 13.77% over 30 days and 35.13% year to date, and the 1 year total shareholder return...

ONEOK recently maintained its quarterly dividend at US$1.07 per share (US$4.28 annualized) and now trades below some estimates of intrinsic value based on discounted cash flow and market multiples, ahead of its August 3 earnings report that is now in the past. This combination of steady cash returns and an apparent valuation gap versus estimated underlying cash flows is drawing fresh attention to ONEOK’s investment case. With the dividend affirmation highlighting capital return consistency,...